Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Development of an adenovirus vector vaccine platform for targeting dendritic cells
HTML
Details
Locations
Year:
2017
Type:
article
Source:
Cancer Gene Therapy
DOI:
10.1038/s41417-017-0002-1
Authors:
Piyush K. Sharma,
Igor P. Dmitriev,
Elena A. Kashentseva,
Geert Raes,
Lijin Li,
Samuel W. Kim,
Zhi-Hong Lu,
Jeffrey M. Arbeit,
Timothy P. Fleming,
Sergey A. Kaliberov,
S. Peter Goedegebuure,
David T. Curiel,
William E. Gillanders
show all 13
Institutions:
Washington University in St. Louis,
Vrije Universiteit Brussel,
VIB-VUB Laboratory Myeloid Cell Immunology,
Barnes-Jewish Hospital,
Alvin J. Siteman Cancer Center
Language:
English
Topic:
Virus-based gene therapy research
Subfield:
Genetics
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
SDG:
Good health and well-being
Open Access status:
green
Funders:
Alvin J. Siteman Cancer Center,
National Cancer Institute,
National Institute of Allergy and Infectious Diseases
Awards:
Novel DC targeted adenovirus vector for malaria vaccine development,
Surgical Oncology Basic Science and Translational Research Training Program,
Cancer Center Support Grant
OpenAlex ID:
W2773464652
FWCI:
2.354
Cites:
74
Cited by:
36
Related to:
10